Stratos Wealth Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $624K | Buy |
12,958
+1,423
| +12% | +$66.3K | 0.01% | 977 |
|
|
2025
Q4 | $559K | Sell |
11,535
-1,887
| -14% | -$93.5K | 0.01% | 1003 |
|
|
2025
Q3 | $634K | Buy |
+13,422
| New | +$648K | 0.01% | 926 |
|
|
2025
Q1 | – | Sell |
-5,057
| Closed | -$244K | – | 1494 |
|
|
2024
Q4 | $244K | Sell |
5,057
-613
| -11% | -$31.2K | ﹤0.01% | 1258 |
|
|
2024
Q3 | $327K | Buy |
5,670
+467
| +9% | +$25.2K | ﹤0.01% | 1112 |
|
|
2024
Q2 | $252K | Sell |
5,203
-252
| -5% | -$12.2K | ﹤0.01% | 1161 |
|
|
2024
Q1 | $265K | Buy |
5,455
+464
| +9% | +$22.7K | ﹤0.01% | 1150 |
|
|
2023
Q4 | $248K | Sell |
4,991
-1,398
| -22% | -$68.4K | ﹤0.01% | 1179 |
|
|
2023
Q3 | $343K | Buy |
6,389
+845
| +15% | +$45.1K | 0.01% | 958 |
|
|
2023
Q2 | $299K | Buy |
5,544
+1,131
| +26% | +$60.9K | 0.01% | 961 |
|
|
2023
Q1 | $240K | Sell |
4,413
-905
| -17% | -$44K | 0.01% | 962 |
|
|
2022
Q4 | $258K | Buy |
5,318
+35
| +0.7% | +$1.54K | 0.01% | 952 |
|
|
2022
Q3 | $201K | Sell |
5,283
-1,551
| -23% | -$69.1K | 0.01% | 1022 |
|
|
2022
Q2 | $342K | Buy |
6,834
+304
| +5% | +$16.1K | 0.01% | 875 |
|
|
2022
Q1 | $335K | Buy |
6,530
+1,995
| +44% | +$103K | 0.01% | 950 |
|
|
2021
Q4 | $227K | Buy |
+4,535
| New | +$224K | 0.01% | 1121 |
|
|
2020
Q2 | – | Sell |
-8,733
| Closed | -$382K | – | 1033 |
|
|
2020
Q1 | $382K | Buy |
+8,733
| New | +$418K | 0.02% | 609 |
|
|
2018
Q4 | – | Sell |
-3,899
| Closed | -$174K | – | 2246 |
|
|
2018
Q3 | $174K | Buy |
+3,899
| New | +$167K | 0.01% | 897 |
|
|
2018
Q2 | – | Sell |
-9,465
| Closed | -$379K | – | 2332 |
|
|
2018
Q1 | $379K | Buy |
9,465
+4,206
| +80% | +$175K | 0.02% | 645 |
|
|
2017
Q4 | $226K | Sell |
5,259
-1,479
| -22% | -$68.2K | 0.01% | 823 |
|
|
2017
Q3 | $335K | Sell |
6,738
-1,777
| -21% | -$86K | 0.02% | 646 |
|
|
2017
Q2 | $408K | Buy |
8,515
+584
| +7% | +$27.9K | 0.02% | 525 |
|
|
2017
Q1 | $359K | Buy |
7,931
+2,415
| +44% | +$102K | 0.02% | 516 |
|
|
2016
Q4 | $223K | Sell |
5,516
-1,192
| -18% | -$47K | 0.01% | 624 |
|
|
2016
Q3 | $256K | Sell |
6,708
-447
| -6% | -$17.9K | 0.02% | 541 |
|
|
2016
Q2 | $299K | Buy |
7,155
+291
| +4% | +$11.9K | 0.02% | 453 |
|
|
2016
Q1 | $276K | Buy |
6,864
+460
| +7% | +$18.5K | 0.02% | 431 |
|
|
2015
Q4 | $273K | Sell |
6,404
-2,147
| -25% | -$98.8K | 0.02% | 446 |
|
|
2015
Q3 | $406K | Buy |
8,551
+145
| +2% | +$7.38K | 0.05% | 301 |
|
|
2015
Q2 | $416K | Sell |
8,406
-4,437
| -35% | -$225K | 0.05% | 289 |
|
|
2015
Q1 | $637K | Buy |
12,843
+7,138
| +125% | +$341K | 0.08% | 239 |
|
|
2014
Q4 | $260K | Buy |
5,705
+1,230
| +27% | +$59.7K | 0.05% | 382 |
|
|
2014
Q3 | $253K | Buy |
+4,475
| New | +$240K | 0.06% | 249 |
|
Other funds holding SNY
MIP
Stratos Wealth Partners's SNY Position: Q1 2026 in Review
Stratos Wealth Partners increased its Sanofi (SNY) stake by 12% in Q1 2026, buying an estimated $66.3K and bringing the position to 12,958 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #977.
Stratos Wealth Partners first reported a position in SNY in Q3 2014 and has held it in 33 quarters since. The position peaked at $637K in Q1 2015. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Stratos Wealth Partners held 12,958 shares of Sanofi worth $624K as of Q1 2026.
- Stratos Wealth Partners bought 1,423 Sanofi shares in Q1 2026, an estimated $66.3K.
- Sanofi made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #977 holding.
- Stratos Wealth Partners first reported a position in Sanofi in Q3 2014 and has held it in 33 quarters since.
- Stratos Wealth Partners's Sanofi position peaked at $637K in Q1 2015.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.